Phibro Animal Health Corp (PAHC) Major Shareholder Bfi Co., Llc Sells 12,000 Shares

Phibro Animal Health Corp (NASDAQ:PAHC) major shareholder Bfi Co., Llc sold 12,000 shares of the business’s stock in a transaction on Wednesday, March 14th. The stock was sold at an average price of $40.12, for a total transaction of $481,440.00. Following the transaction, the insider now directly owns 24,000 shares of the company’s stock, valued at approximately $962,880. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Bfi Co., Llc also recently made the following trade(s):

How to Become a New Pot Stock Millionaire
  • On Wednesday, March 7th, Bfi Co., Llc sold 12,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $38.92, for a total transaction of $467,040.00.
  • On Monday, March 5th, Bfi Co., Llc sold 12,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $39.35, for a total transaction of $472,200.00.
  • On Thursday, March 1st, Bfi Co., Llc sold 12,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $38.20, for a total transaction of $458,400.00.
  • On Friday, February 23rd, Bfi Co., Llc sold 14,802 shares of Phibro Animal Health stock. The stock was sold at an average price of $38.15, for a total transaction of $564,696.30.

Shares of Phibro Animal Health Corp (NASDAQ:PAHC) traded up $0.30 on Friday, hitting $40.25. 243,291 shares of the stock were exchanged, compared to its average volume of 128,934. The firm has a market capitalization of $1,605.63, a price-to-earnings ratio of 26.31, a P/E/G ratio of 2.83 and a beta of 0.97. The company has a debt-to-equity ratio of 1.82, a current ratio of 3.12 and a quick ratio of 1.75. Phibro Animal Health Corp has a 1-year low of $26.70 and a 1-year high of $41.05.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, February 5th. The company reported $0.44 EPS for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.06. The business had revenue of $205.90 million during the quarter, compared to analyst estimates of $194.90 million. Phibro Animal Health had a net margin of 7.90% and a return on equity of 40.49%. The firm’s revenue for the quarter was up 7.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.39 earnings per share. equities research analysts predict that Phibro Animal Health Corp will post 1.69 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 28th. Stockholders of record on Wednesday, March 7th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date is Tuesday, March 6th. Phibro Animal Health’s dividend payout ratio is currently 26.14%.

Several institutional investors and hedge funds have recently made changes to their positions in PAHC. First Trust Advisors LP acquired a new position in shares of Phibro Animal Health during the third quarter valued at about $569,000. Prudential Financial Inc. raised its position in shares of Phibro Animal Health by 59.0% during the third quarter. Prudential Financial Inc. now owns 141,760 shares of the company’s stock valued at $5,253,000 after buying an additional 52,590 shares during the last quarter. Principal Financial Group Inc. raised its position in Phibro Animal Health by 1.8% in the third quarter. Principal Financial Group Inc. now owns 146,814 shares of the company’s stock worth $5,439,000 after purchasing an additional 2,617 shares in the last quarter. Bessemer Group Inc. raised its position in Phibro Animal Health by 103.0% in the third quarter. Bessemer Group Inc. now owns 34,100 shares of the company’s stock worth $1,263,000 after purchasing an additional 17,300 shares in the last quarter. Finally, BNP Paribas Arbitrage SA raised its position in Phibro Animal Health by 69.8% in the third quarter. BNP Paribas Arbitrage SA now owns 10,076 shares of the company’s stock worth $373,000 after purchasing an additional 4,143 shares in the last quarter. 48.09% of the stock is owned by institutional investors and hedge funds.

PAHC has been the subject of a number of research analyst reports. BidaskClub lowered shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 2nd. ValuEngine raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, February 28th. Zacks Investment Research raised shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Monday, January 8th. Morgan Stanley upped their price objective on shares of Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a research report on Wednesday, February 7th. Finally, Credit Suisse Group upped their price objective on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research report on Tuesday, February 6th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. Phibro Animal Health presently has a consensus rating of “Hold” and an average target price of $38.20.

COPYRIGHT VIOLATION NOTICE: This report was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of US & international copyright and trademark legislation. The original version of this report can be accessed at https://www.com-unik.info/2018/03/17/phibro-animal-health-corp-pahc-major-shareholder-bfi-co-llc-sells-12000-shares.html.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit